Fig. 1From: Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cellsCobimetinib mediated cytotoxicity against NB cells. Triplicate wells of cells from six NB cell lines were treated with increasing concentrations of cobimetinib or corresponding concentrations of vehicle control (DMSO) and cell viability was evaluated after four days in culture using automated microscopy. Results presented show cell growth inhibition compared to DMSO control. Data presented are representative of three separate experimentsBack to article page